Fate Therapeutics, Inc.FATENASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank93
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Percentile
P93
Near historical high
vs 2Y Ago
0.8x
Contraction
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
202529.76%
2024-10.37%
202338.22%
2022-42.12%
2021-69.41%
2020-27.16%
2019-50.13%
2018-59.27%
2017-31.79%
2016-15.05%